Favorable surgical outcomes for either second primary lung cancer or intrapulmonary metastasis after resection of nonsmall cell lung cancer.

Yoshihiro IshikawaYukio TsuuraKoji OkudelaTomoe SawazumiHiromasa AraiKohei AndoTetsukan WooTakao MorohoshiKenji InafukuNobuaki KobayashiYasushi Rino

Published in: Interdisciplinary cardiovascular and thoracic surgery (2024)

Surgery for cN0 metachronous lung cancer is safe and shows good outcomes. There were no statistically significant differences in the SPLC and IPM results. Caution should be exercised when operating on patients with overlapping SCC.

Keyphrases

minimally invasive
coronary artery bypass
cell therapy
stem cells
squamous cell carcinoma
lymph node metastasis
metabolic syndrome
coronary artery disease
bone marrow